Skip to content
Home/Companies/Healthcare/CinCor Pharma
CP

CinCor Pharma

Healthcare·US·Exited·Held 7yr

CinCor Pharma is a healthcare company, headquartered in United States.

Entry
2019
Hold
7yr
Exit
–
Est. EV
–

Who owns CinCor Pharma?

CinCor Pharma was owned by General Atlantic through General Atlantic Growth Equity Fund (2024 vintage) since 2019. Across its history, CinCor Pharma has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

General Atlantic
Most recent investor
General Atlantic
General Atlantic Growth Equity Fund · 2024 · Growth
2 ownership periods · full history below

Key facts

HQUnited States
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2023 to .
Co-invest · 2 holders · 2019 · present
Sofinnova Partners
Sofinnova PartnersExited 2023
2019 · 2023 · Sofinnova Capital IX · 2018 · Life Sciences VC
Trade Sale · to
MOIC
–
General Atlantic
General AtlanticExited
2019 · General Atlantic Growth Equity Fund · 2024 · Growth
MOIC
–

More from General Atlantic Growth Equity Fund

Other portfolio companies in the same fund.

A Place for Mom
Active
Business ServicesUS
Absolute Barbecue
Active
ConsumerIndia
Adyen
Active
TMTNetherlands
Akero Therapeutics
Active
HealthcareUS
Alkami Technology
Active
SoftwareUS
Amagi
Active
TMTUS

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings